TISSUE & FFPE COHORT COLLECTIONS

Bladder cancer tissue microarrays & FFPE blocks

Compare urothelial carcinoma arrays, including primary tumors, metastatic tissue and selected treatment-follow-up collections. For FFPE blocks, share your tissue and study requirements with our team.

THE ARRAYS

Bladder cancer arrays (4)

Collection types in this TMA catalog

Explore the tissue composition and sampling groups represented in these arrays.

Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.

FFPE TISSUE BLOCKS

Bladder cancer FFPE blocks for your study

Bladder and urothelial FFPE profiles include muscle-invasive disease by cisplatin eligibility, as well as non-muscle-invasive bladder cancer.

FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.

Explore Bladder / urothelial cancer FFPE cohort profiles

Collection features

  • Advanced disease (III/IV)
  • Longitudinal data
  • Primary & matched metastases
  • Pre / post standard-of-care treatment

Features vary by profile and donor; confirm the required coverage for your study.

Profiles describe documented collections, not live inventory. Features vary by profile and donor. Pre/post treatment collections are not necessarily donor-matched; availability and required coverage are confirmed for your study.

SELECTING YOUR ARRAY

Selecting bladder cancer tissue for your study

Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.

Bladder Cancer TMA: Immunotherapy Follow-up

This bladder urothelial carcinoma tissue microarray includes pre-treatment and post-immunotherapy samples with pembrolizumab/nivolumab follow-up data. The pre/post groups are not donor matched.

Bladder Cancer TMA: Matched & Normal Tissue

This bladder urothelial carcinoma tissue microarray includes primary tumors, matched metastases and non-malignant bladder tissue, with histopathology data. Review the array map to distinguish the tumor, metastatic and normal tissue entries.

Bladder Cancer TMA: Primary & Metastases

This tissue microarray lists primary bladder urothelial carcinoma, matched metastases and renal cell carcinoma metastases, with histopathology data. Review the array map to distinguish the listed tissue groups.